The story of Viagra presents a challenging picture for shareholders. While the initial introduction generated substantial gains, the end of its intellectual property protection opened the floodgates to off-brand https://webnowmedia.com/story7114856/sildenafil-and-big-pharma-a-precarious-opportunity